Story

Encompass Health Reaffirmed as Top SMidCap Pick by TD Cowen After Strong Q2 Earnings

ENTHMSVIIDZHZH-TWJAKOHI
Aug 11, 20262 min read
Encompass Health Reaffirmed as Top SMidCap Pick by TD Cowen After Strong Q2 Earnings
Text size
Background

TD Cowen has reaffirmed Encompass Health Corporation (NYSE: EHC) as its top small- and mid-cap (SMidCap) stock pick, citing the company's robust second-quarter fiscal 2026 results which surpassed analyst expectations and prompted an upward revision to its full-year guidance.

Earnings Beat Expectations

Encompass Health reported strong financial results for the second quarter, beating consensus estimates despite facing certain headwinds. The healthcare company delivered an adjusted EBITDA of $348 million, a 3% beat over analyst forecasts, even after absorbing an $11.5 million year-over-year headwind from net supplemental discharge payments.

Key financial highlights from the quarter include:

  • Revenue: $1.597 billion, representing a 10% year-over-year increase and exceeding consensus estimates by 2%.
  • Adjusted Earnings Per Share (EPS): $1.55, an 11% increase from the prior year and above the analyst expectation of $1.49.

Strong Operational Growth

Sample IUX Markets – In-articleAd

The company's performance was driven by solid volume growth and operational efficiency. According to the report, same-store volume growth reached 2.8% year-over-year, outperforming the consensus estimate of 2.0%. Total discharge growth for the quarter was 5.6%.

Encompass Health attributed the strong results to high patient demand, improved facility occupancy, and a reduction in costs associated with premium labor. The company also expanded its capacity by adding 100 new beds during the quarter through both new facility openings and expansions of existing locations.

Raised Guidance and Shareholder Returns

Reflecting its strong performance and positive outlook, Encompass Health raised its full-year 2026 financial guidance. The company now projects revenue in the range of $6.410 billion to $6.490 billion, an increase from its prior forecast.

In a further sign of confidence, management authorized a new $1 billion share repurchase program. Such programs are often viewed by investors as a signal that a company's leadership believes its stock is undervalued and is confident in its future cash flow and balance sheet flexibility.

Read next

More on Stocks
Back to latest news

LATEST